Summary

The global Periodontal disease treatment Equipment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, at a CAGR of 5.9% during the forecast period. This is due to increased awareness about the connection between oral health and overall systemic health, bringing the focus of both the patients and healthcare provider towards periodontal care. Increased government-driven campaigns to promote hygiene in the oral cavity and increased provision of dental insurance coverage have also added momentum towards this market. The increase in dental care infrastructures, especially in developing economies, is further fueling this market. In addition, the adoption of minimally invasive procedures and biologics as well as the discovery of new drugs has increased the efficacy of treatment, adding more fuel to the growth of the periodontal disease market players over the forecast period of 2024-2030.
“The chronic periodontitis segment of periodontal disease treatment market to hold second largest position forecast period.”
Based on the disease type, the chronic periodontitis segment is anticipated to hold second largest share position during forecast period in periodontal disease treatment equipment market. This is due to increasing number of older populations are suffering from periodontal diseases. The condition will become increasingly common since chronic periodontitis is often found in older patients. Enhanced awareness regarding the relationship between oral health and systemic conditions, such as diabetes mellitus and cardiovascular disease, is generating a greater demand among patients to receive preventive and therapeutic care, which is increasing diagnoses and subsequent treatment adoption.
“The guided tissue regeneration segment is the fastest growing segment in periodontal disease treatment market.”
Based on treatment type, the periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue graft, bone grafting, guided tissue regeneration and other treatments. The guided tissue regeneration segment is expected to grow at the highest CAGR due to its pivotal role in periodontal disease treatment research and development (R&D). Advances in biomaterials and tissue engineering have been made, leading to newer and more efficient and biocompatible membranes with better outcomes. GTR procedures are increasingly being adopted by dental professionals, and their growing training and availability of specialized equipment have made it highly potential. Favorable reimbursement policies in different regions coupled with an upsurge of cosmetic dentistry have also played an important role in the high growth rate of the GTR market.

“Europe accounted for the second largest share of the periodontal disease treatment market by region.”
The global periodontal disease treatment equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the second largest regional market for periodontal disease treatment equipment, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
Europe holds the second-largest position in the periodontal disease treatment equipment market. The region has a well-established health infrastructure which provides better access to advanced dental care. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in Europe. The high awareness of oral health and preventive care services available in European countries further spur the expansion of this market. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting periodontal treatments. Ongoing research and development in dental technologies and biomaterials, including countries like Germany and Switzerland, also support this expansion in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: Directors–50%, Managers–30% and Others–20%
• By Region: North America–38%, Europe–26%, Asia Pacific–15%, Latin America–11%, Middle East & Africa- 7%, GCC Countries- 3%

The major players operating in the periodontal disease treatment equipment market market are DENTSPLY SIRONA Inc. (US), Envista Holdings Corporation (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (US), PreXion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US), and Bien-Air Dental (US).
Research Coverage
This report studies the periodontal disease treatment equipment market based on disease type, streatment type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Analysis of Key divers( Development of technologically advanced solutions, Rise in oral health disorders, Rising demand for advanced cosmetic dental procedures, Growing market for dental tourism in emerging countries restraints (High cost of dental imaging systems and lack of reimbursement for dental procedures, opportunity (Impact of DSOs on dental industry, Increasing number of dental laboratories investing in CAD/CAM technologies and Growing focus on emerging markets)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the periodontal disease treatment market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the periodontal disease treatment market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the periodontal disease treatment market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 MARKET SCOPE 28
1.3.1 MARKET SEGMENTATION 28
1.3.2 INCLUSIONS & EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 29
1.4 MARKET STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
2.2 MARKET SIZE ESTIMATION 37
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 42
2.4 MARKET SHARE ASSUMPTIONS 43
2.5 RISK ASSESSMENT 44
2.6 RESEARCH LIMITATIONS 44
2.6.1 METHODOLOGY-RELATED LIMITATIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 PERIODONTAL DISEASE TREATMENT MARKET OVERVIEW 49
4.2 ASIA PACIFIC: PERIODONTAL DISEASE TREATMENT MARKET,
BY END USER & COUNTRY (2023) 50
4.3 PERIODONTAL DISEASE TREATMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
4.4 REGIONAL MIX: PERIODONTAL DISEASE TREATMENT MARKET (2024−2030) 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing prevalence of oral disorders 53
5.2.1.2 Rising cases of edentulism 53
5.2.1.3 Emergence of innovative dental treatment procedures 54
5.2.1.4 Expanding market for dental tourism in emerging economies 55
5.2.2 RESTRAINTS 56
5.2.2.1 High cost of advanced treatments and inadequate reimbursements for dental procedures 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Impact of DSOs on dental industry 56
5.2.3.2 Growing awareness about oral health 58
5.2.4 CHALLENGES 59
5.2.4.1 Shortage of skilled dental practitioners 59
5.3 INDUSTRY TRENDS 59
5.3.1 INCREASING PREFERENCE OF MINIMALLY INVASIVE DENTAL PROCEDURES 59
5.3.2 MARKET CONSOLIDATION 60
5.3.3 DENTAL INSURANCE IN US 60
5.4 TECHNOLOGY ANALYSIS 61
5.4.1 KEY TECHNOLOGIES 61
5.4.1.1 3D printers 61
5.4.1.2 Artificial intelligence 61
5.4.2 ADJACENT TECHNOLOGIES 62
5.4.2.1 Virtual reality 62
5.4.2.2 Laser dentistry 62
5.5 VALUE CHAIN ANALYSIS 62
5.6 ECOSYSTEM MAP 63
5.7 SUPPLY CHAIN ANALYSIS 64
5.8 REGULATORY ANALYSIS 64
5.8.1 REGULATORY LANDSCAPE 64
5.8.1.1 US 64
5.8.1.2 EU 65
5.8.1.3 China 66
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.9 PATENT ANALYSIS 69
5.9.1 PATENT PUBLICATION TRENDS FOR PERIODONTAL DISEASE TREATMENT 69
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 70
5.10 TRADE ANALYSIS 72
5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
5.12 ADJACENT MARKETS FOR PERIODONTAL DISEASE TREATMENT 75
5.13 CASE STUDY ANALYSIS 75
5.13.1 CASE STUDY 1: INNOVATION TRACKING, TECHNOLOGY ASSESSMENT, AND PRODUCT LAUNCHES IN ANTIMICROBIAL AGENTS & COATING SUBSTANCES FOR DENTAL IMPLANTS 75
5.13.2 CASE STUDY 2: CUSTOMIZED STUDY FOR MEA 76
5.13.3 CASE STUDY 3: CUSTOMIZED STUDY FOR LATIN AMERICA 76
5.14 PORTER’S FIVE FORCES ANALYSIS 77
5.14.1 THREAT OF NEW ENTRANTS 78
5.14.2 THREAT OF SUBSTITUTES 78
5.14.3 BARGAINING POWER OF SUPPLIERS 78
5.14.4 BARGAINING POWER OF BUYERS 78
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.15 KEY CONFERENCES & EVENTS, 2024 79
5.16 PRICING ANALYSIS 80
5.16.1 AVERAGE COST OF PERIODONTAL DISEASE TREATMENT SYSTEMS (2021−2023) (USD) 80
5.16.2 AVERAGE COST RANGE OF PERIODONTAL DISEASE TREATMENT, BY REGION (2021−2023) (USD) 80
5.16.3 AVERAGE SELLING PRICE OF PERIODONTAL DISEASE TREATMENT,
BY PRODUCT TYPE 81
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 81
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 81
5.17.2 BUYING CRITERIA 82
5.18 UNMET NEEDS IN PERIODONTAL DISEASE TREATMENT MARKET 83
5.19 INVESTMENT & FUNDING SCENARIO 84
5.20 PREVALENCE OF GINGIVAL CASES IN KEY COUNTRIES 84
5.21 ANALYSIS OF TOTAL NUMBER OF SURGERIES IN KEY COUNTRIES 85
6 PERIODONTAL DISEASE TREATMENT MARKET, BY PRODUCT 86
6.1 INTRODUCTION 87
6.2 EQUIPMENT 87
6.2.1 GROWING PREFERENCE FOR MIS PROCEDURES TO DRIVE MARKET 87
6.3 CONSUMABLES 88
6.3.1 RECURRING NATURE & FREQUENT PURCHASE TO PROPEL MARKET 88
6.4 MEDICATION 90
6.4.1 GROWING AWARENESS OF ORAL HEALTH AND IMPROVEMENTS IN ANTIBIOTICS TO SUPPORT MARKET 90
7 PERIODONTAL DISEASE TREATMENT MARKET, BY DISEASE 92
7.1 INTRODUCTION 93
7.2 GINGIVITIS 93
7.2.1 ACUTE GINGIVITIS 95
7.2.1.1 Prevalence in children and adolescents to drive market 95
7.2.2 RECURRENT GINGIVITIS 96
7.2.2.1 Recurrent cases of bacterial infection due to poor oral hygiene to fuel market 96
7.2.3 CHRONIC GINGIVITIS 97
7.2.3.1 Prolonged inflammation of gums to support market growth 97

7.3 CHRONIC PERIODONTITIS 98
7.3.1 INCREASING CASES OF EDENTULISM TO FUEL MARKET 98
7.4 AGGRESSIVE PERIODONTITIS 100
7.4.1 RAPID TOOTH LOSS AND UNDERLYING HEALTH CONDITIONS TO CONTRIBUTE TO MARKET GROWTH 100
7.5 OTHER DISEASES 101
8 PERIODONTAL DISEASE TREATMENT MARKET, BY TREATMENT 103
8.1 INTRODUCTION 104
8.2 NON-SURGICAL TREATMENT 104
8.2.1 SCALING 106
8.2.1.1 Ability to inhibit bacterial infection to fuel uptake 106
8.2.2 ROOT PLANING 107
8.2.2.1 Reduction of gingival pockets to support market growth 107
8.2.3 MEDICATION THERAPY 109
8.2.3.1 Topical therapy 110
8.2.3.1.1 Uptake of antimicrobial gels and mouth rinses to drive market 110
8.2.3.2 Systemic therapy 112
8.2.3.2.1 Utilization of host-modulating agents and antibiotics to drive market 112
8.3 FLAP SURGERY/POCKET REDUCTION THERAPY 113
8.3.1 COMMON SURGICAL PROCEDURE FOR ADVANCED PERIODONTAL DISEASES TO DRIVE MARKET 113
8.4 SOFT TISSUE GRAFT 114
8.4.1 PREVALENCE OF GINGIVAL RECESSION TO FUEL UPTAKE 114
8.5 BONE GRAFTING 115
8.5.1 GROWING FOCUS ON REGENERATION OF BONES TO FUEL UPTAKE 115
8.6 GUIDED TISSUE REGENERATION 117
8.6.1 HIGH SUCCESS RATE TO PROPEL MARKET 117
8.7 OTHER TREATMENTS 118
9 PERIODONTAL DISEASE TREATMENT MARKET, BY END USER 119
9.1 INTRODUCTION 120
9.2 HOSPITALS 120
9.2.1 AVAILABILITY OF ADVANCED EQUIPMENT FOR DENTISTRY AND GROWING FOCUS ON DENTAL TOURISM TO PROPEL MARKET 120
9.3 PRIVATE & DSO CLINICS 122
9.3.1 INCREASING ESTABLISHMENT OF PRIVATE PRACTICES TO DRIVE MARKET 122
9.4 ACADEMIC & RESEARCH INSTITUTES 124
9.4.1 R&D FUNDING INITIATIVES TO SUPPORT MARKET GROWTH 124

10 PERIODONTAL DISEASE TREATMENT MARKET, BY REGION 126
10.1 INTRODUCTION 127
10.2 NORTH AMERICA 127
10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 128
10.2.2 US 131
10.2.2.1 Favorable reimbursement policies for dental procedures to drive market 131
10.2.3 CANADA 134
10.2.3.1 Rising incidence of dental caries to drive market 134
10.3 EUROPE 138
10.3.1 EUROPE: MACROECONOMIC OUTLOOK 141
10.3.2 GERMANY 141
10.3.2.1 Hub for advanced dentistry technologies to propel market 141
10.3.3 FRANCE 145
10.3.3.1 Favorable government healthcare policies to fuel uptake 145
10.3.4 UK 148
10.3.4.1 Increasing incidence of dental disorders to drive market 148
10.3.5 ITALY 151
10.3.5.1 Low-cost dental treatments to support market growth 151
10.3.6 SPAIN 154
10.3.6.1 Privatization of dental clinics and uptake of advanced technologies to support market growth 154
10.3.7 REST OF EUROPE 158
10.4 ASIA PACIFIC 161
10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 162
10.4.2 CHINA 165
10.4.2.1 Growing prevalence of dental diseases to drive market growth in China 165
10.4.3 JAPAN 168
10.4.3.1 Rising geriatric population and favorable reimbursement scenario to support market growth 168
10.4.4 INDIA 171
10.4.4.1 Expansion of dentistry and growing awareness of oral hygiene to drive market 171
10.4.5 AUSTRALIA 175
10.4.5.1 Favorable government initiatives and growing prevalence of dental diseases to drive market 175
10.4.6 SOUTH KOREA 178
10.4.6.1 Increasing cases of edentulism to fuel uptake 178
10.4.7 REST OF ASIA PACIFIC 181

10.5 LATIN AMERICA 184
10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 184
10.5.2 MEXICO 187
10.5.2.1 Growth in dental tourism to drive market 187
10.5.3 BRAZIL 191
10.5.3.1 Trend of cosmetic dentistry to propel market 191
10.5.4 ARGENTINA 194
10.5.4.1 increasing use of CAD/CAM systems to support market growth 194
10.5.5 REST OF LATIN AMERICA 197
10.6 MIDDLE EAST & AFRICA 200
10.6.1 RISING AWARENESS ABOUT DENTAL HYGIENE TO SUPPORT MARKET GROWTH 200
10.6.2 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 200
10.7 GCC COUNTRIES 203
10.7.1 GROWING DEMAND FOR PERSONALIZED DENTISTRY TO DRIVE MARKET 203
10.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK 203
11 COMPETITIVE LANDSCAPE 207
11.1 INTRODUCTION 207
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 207
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PERIODONTAL DISEASE TREATMENT MARKET 208
11.3 REVENUE ANALYSIS, 2019−2023 209
11.4 MARKET SHARE ANALYSIS, 2023 209
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 212
11.5.1 STARS 212
11.5.2 EMERGING LEADERS 212
11.5.3 PERVASIVE PLAYERS 212
11.5.4 PARTICIPANTS 212
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 214
11.5.5.1 Company footprint 214
11.5.5.2 Region footprint 215
11.5.5.3 Product footprint 216
11.5.5.4 Disease footprint 217
11.5.5.5 Treatment footprint 218
11.5.5.6 End-user footprint 219
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 220
11.6.1 PROGRESSIVE COMPANIES 220
11.6.2 RESPONSIVE COMPANIES 220
11.6.3 DYNAMIC COMPANIES 220
11.6.4 STARTING BLOCKS 220
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 222

11.7 COMPANY VALUATION & FINANCIAL METRICS 223
11.7.1 FINANCIAL METRICS 223
11.7.2 COMPANY VALUATION 223
11.8 BRAND/PRODUCT COMPARISON 224
11.9 R&D EXPENDITURE 225
11.10 COMPETITIVE SCENARIO 225
11.10.1 PRODUCT LAUNCHES & APPROVALS 225
11.10.2 DEALS 226
11.10.3 EXPANSIONS 227
12 COMPANY PROFILES 228
12.1 KEY PLAYERS 228
12.1.1 DENTSPLY SIRONA 228
12.1.1.1 Business overview 228
12.1.1.2 Products offered 230
12.1.1.3 Recent developments 231
12.1.1.3.1 Product launches 231
12.1.1.3.2 Deals 231
12.1.1.4 MnM view 232
12.1.1.4.1 Key strengths 232
12.1.1.4.2 Strategic choices 232
12.1.1.4.3 Weaknesses & competitive threats 232
12.1.2 ENVISTA HOLDINGS CORPORATION 233
12.1.2.1 Business overview 233
12.1.2.2 Products offered 234
12.1.2.3 Recent developments 235
12.1.2.3.2 Product approvals 235
12.1.2.3.3 Deals 235
12.1.2.4 MnM view 236
12.1.2.4.1 Key strengths 236
12.1.2.4.2 Strategic choices 236
12.1.2.4.3 Weaknesses & competitive threats 236
12.1.3 INSTITUT STRAUMANN AG 237
12.1.3.1 Business overview 237
12.1.3.2 Products offered 238
12.1.3.3 Recent developments 239
12.1.3.3.1 Product launches 239
12.1.3.3.2 Deals 239
12.1.3.3.3 Expansions 239
12.1.3.4 MnM view 240
12.1.3.4.1 Key strengths 240
12.1.3.4.2 Strategic choices 240
12.1.3.4.3 Weaknesses & competitive threats 240
12.1.4 HENRY SCHEIN, INC. 241
12.1.4.1 Business overview 241
12.1.4.2 Products offered 242
12.1.4.3 Recent developments 243
12.1.4.3.1 Deals 243
12.1.4.4 MnM view 244
12.1.4.4.1 Key strengths 244
12.1.4.4.2 Strategic choices 244
12.1.4.4.3 Weaknesses & competitive threats 244
12.1.5 BIOLASE, INC. 245
12.1.5.1 Business overview 245
12.1.5.2 Products offered 246
12.1.5.3 Recent developments 247
12.1.5.3.1 Product launches 247
12.1.6 GEISTLICH PHARMA AG 248
12.1.6.1 Business overview 248
12.1.6.2 Products offered 248
12.1.7 J. MORITA CORP. 249
12.1.7.1 Business overview 249
12.1.7.2 Products offered 249
12.1.7.3 Recent developments 250
12.1.7.3.1 Product launches 250
12.1.7.3.2 Deals 250
12.1.8 NAKANISHI INC. 251
12.1.8.1 Business overview 251
12.1.8.2 Products offered 252
12.1.9 A-DEC INC. 253
12.1.9.1 Business overview 253
12.1.9.2 Products offered 253
12.1.10 RTI SURGICAL 254
12.1.10.1 Business overview 254
12.1.10.2 Products offered 254
12.1.10.3 Recent developments 255
12.1.10.3.1 Deals 255
12.1.11 YOSHIDA DENTAL MFG.CO. LTD. 256
12.1.11.1 Business overview 256
12.1.11.2 Products offered 256
12.1.12 KEYSTONE DENTAL INC. 257
12.1.12.1 Business overview 257
12.1.12.2 Products offered 257
12.1.12.3 Recent developments 258
12.1.12.3.1 Deals 258
12.1.13 ULTRADENT PRODUCTS, INC. 259
12.1.13.1 Business overview 259
12.1.13.2 Products offered 259
12.1.14 BEGO GMBH & CO. KG 260
12.1.14.1 Business overview 260
12.1.14.2 Products offered 260
12.1.14.3 Recent developments 261
12.1.14.3.1 Deals 261
12.1.15 DENTALEZ INC. 262
12.1.15.1 Business overview 262
12.1.15.2 Products offered 262
12.1.15.3 Recent developments 263
12.1.15.3.1 Product launches 263
12.1.16 PARKELL, INC. 264
12.1.16.1 Business overview 264
12.1.16.2 Products offered 264
12.1.16.3 Recent developments 265
12.1.16.3.1 Product launches 265
12.2 OTHER PLAYERS 266
12.2.1 MILLENNIUM DENTAL TECHNOLOGIES INC. 266
12.2.2 BRASSELER USA 266
12.2.3 AMD LASERS 267
12.2.4 NOVA INSTRUMENTS 267
12.2.5 BOTISS BIOMATERIALS GMBH 268
12.2.6 CONVERGENT DENTAL 268
12.2.7 NOVABONE 269
12.2.8 REGENITY 270
12.2.9 HANNOX INTERNATIONAL CORP. 270
13 APPENDIX 271
13.1 DISCUSSION GUIDE 271
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 276
13.3 CUSTOMIZATION OPTIONS 278
13.4 RELATED REPORTS 278
13.5 AUTHOR DETAILS 279